101 related articles for article (PubMed ID: 15621844)
1. Interferon-induced lupus nephritis in a patient with chronic myeloid leukemia.
Goyal HK; Wadhwa J; Arora B; Dawar R; Agarwal SK; Singh D
Leuk Lymphoma; 2005 Mar; 46(3):481-2. PubMed ID: 15621844
[No Abstract] [Full Text] [Related]
2. [Interferon in the treatment of Philadelphia-positive chronic myeloid leukemia].
Morra E; Alimena G; Lazzarino M; Liberati AM; Montefusco E; Inverardi D; Bernasconi P; Mancini M; Donti E; Senatore M
Haematologica; 1990; 75 Suppl 4():33-40. PubMed ID: 1705912
[No Abstract] [Full Text] [Related]
3. Into interferon.
Salaman JR
Eur J Surg Oncol; 1994 Jun; 20(3):251-2. PubMed ID: 7514142
[No Abstract] [Full Text] [Related]
4. Interferon induced severe digital ischaemia in chronic myeloid leukaemia--successful treatment using ketanserin.
Sachithanandan A; Cuthbert RJ; Barros d'Sa AA
Eur J Vasc Endovasc Surg; 2001 Nov; 22(5):474-6. PubMed ID: 11735190
[No Abstract] [Full Text] [Related]
5. Collection of Ph-negative progenitor cells from interferon responsive patients with chronic myeloid leukemia: effect of granulocyte-colony-stimulating factor mobilization.
Olavarria E; Parker S; Craddock C; Philpott N; Tiniakou M; Chase A; Kanfer E; Apperley JF; Goldman JM
Haematologica; 2000 Jun; 85(6):647-52. PubMed ID: 10870123
[TBL] [Abstract][Full Text] [Related]
6. Unexpected occurrence of second malignancies in patients treated with interferon followed by imatinib mesylate for chronic myelogenous leukemia.
Roy L; Guilhot J; Martineau G; Larchée R; Guilhot F
Leukemia; 2005 Sep; 19(9):1689-92. PubMed ID: 16015386
[No Abstract] [Full Text] [Related]
7. Thriving with chronic myeloid leukaemia.
Morris RH
Lancet; 2001 Dec; 358 Suppl():S12. PubMed ID: 11784561
[No Abstract] [Full Text] [Related]
8. Chronic myeloid leukemia following therapy with imatinib mesylate (Gleevec). Bone marrow histopathology and correlation with genetic status.
Frater JL; Tallman MS; Variakojis D; Druker BJ; Resta D; Riley MB; Hrisinko MA; Peterson LC
Am J Clin Pathol; 2003 Jun; 119(6):833-41. PubMed ID: 12817431
[TBL] [Abstract][Full Text] [Related]
9. [Marked reduction of BCR-ABL fusion chromosome positive cells with interferon therapy combined with short-term imatinib in chronic myelogenous leukemia].
Ajima A; Takayama N; Hasegawa Y; Kojima H; Nagasawa T
Gan To Kagaku Ryoho; 2003 Nov; 30(12):1997-9. PubMed ID: 14650975
[TBL] [Abstract][Full Text] [Related]
10. Therapy of chronic myelogenous leukemia with interferon.
Kurzrock R; Gutterman JU; Kantarjian H; Talpaz M
Cancer Invest; 1989; 7(1):83-91. PubMed ID: 2472193
[No Abstract] [Full Text] [Related]
11. Successful allogeneic bone marrow transplant for chronic myeloid leukaemia despite previous interferon-induced cardiomyopathy.
Broady R; Hawkins T; Browett P; Palmer S
Bone Marrow Transplant; 1998 Apr; 21(8):833-4. PubMed ID: 9603410
[TBL] [Abstract][Full Text] [Related]
12. Imatinib induces a cytogenetic response in blast crisis or interferon failure chronic myeloid leukemia patients with e19a2 BCR-ABL transcripts.
Lee JJ; Kim HJ; Kim YJ; Lee S; Hwang JY; Kim YL; Kim DW
Leukemia; 2004 Sep; 18(9):1539-40. PubMed ID: 15284852
[No Abstract] [Full Text] [Related]
13. VEGF in chronic myeloid leukemia treated with interferon and imatinib.
Aguayo A
Leuk Res; 2014 Jun; 38(6):660-1. PubMed ID: 24726782
[No Abstract] [Full Text] [Related]
14. [Interferons in the treatment of hematological diseases].
Jantunen E; Nousiainen T
Duodecim; 1998; 114(12):1240-7. PubMed ID: 11524770
[No Abstract] [Full Text] [Related]
15. [The role of alpha-interferon therapy in chronic myeloid leukemia].
Udvardy M
Orv Hetil; 2000 Jan; 141(2):67-70. PubMed ID: 10686779
[TBL] [Abstract][Full Text] [Related]
16. Interferon-induced vasospasm in chronic myeloid leukaemia.
Zeidman A; Dicker D; Mittelman M
Acta Haematol; 1998; 100(2):94-6. PubMed ID: 9792941
[TBL] [Abstract][Full Text] [Related]
17. [Effect of retinoic acid on the cytogenetic remission in the first chronic phase of chronic myeloid leukemia treated with interferon].
Egyed M; Mihályfalvi Z; Kollár B; Rumi G; Keller E; Vass J; Fekete S
Orv Hetil; 2001 Nov; 142(44):2421-5. PubMed ID: 11766235
[TBL] [Abstract][Full Text] [Related]
18. Interferon in chronic myeloid leukaemia: past and future.
Guilhot F; Roy L; Saulnier PJ; Guilhot J
Best Pract Res Clin Haematol; 2009 Sep; 22(3):315-29. PubMed ID: 19959083
[TBL] [Abstract][Full Text] [Related]
19. Imatinib activity in vitro in tumor cells from patients with chronic myeloid leukemia in chronic phase and blast crisis.
Olsson-Strömberg U; Aleskog A; Björnberg A; Höglund M; Simonsson B; Bengtsson M; Barbany G; Larsson R; Lindhagen E
Anticancer Drugs; 2006 Jul; 17(6):631-9. PubMed ID: 16917208
[TBL] [Abstract][Full Text] [Related]
20. Deregulated expression of Cdc6 as BCR/ABL-dependent survival factor in chronic myeloid leukemia cells.
Zhang JH; He YL; Zhu R; Du W; Xiao JH
Tumour Biol; 2017 Jun; 39(6):1010428317713394. PubMed ID: 28639894
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
